title: Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.
authors.affiliation: Second Medical Department, Aristotle University, Thessaloniki, Greece. pashospas@hotmail.com
authors.forename: Paschalis
authors.initials: P
authors.lastname: Paschos
authors.forename: Efthimia
authors.initials: E
authors.lastname: Vlachaki
authors.forename: Chrisoula
authors.initials: C
authors.lastname: Pasvanti
authors.forename: Emmanouil
authors.initials: E
authors.lastname: Sinakos
authors.forename: Anastasia
authors.initials: A
authors.lastname: Kalpaka
authors.forename: Philippos
authors.initials: P
authors.lastname: Klonizakis
authors.forename: Vasilios
authors.initials: V
authors.lastname: Perifanis
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D015913:Chelation Therapy; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006115:Greece; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006720:Homozygote; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D007502:Iron Chelating Agents / Q000627:therapeutic use; D019190:Iron Overload / Q000150:complications / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000737:chemistry*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D065227:Transfusion Reaction; D016896:Treatment Outcome; D017086:beta-Thalassemia / Q000139:chemically induced* / Q000150:complications / Q000235:genetics / Q000628:therapy
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007502:Iron Chelating Agents; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin